130 related articles for article (PubMed ID: 3749815)
1. The terminal complement complex in sera deficient in the eighth component of complement (C8).
Mollnes TE; Lea T; Rogde S; Tedesco F
Scand J Immunol; 1986 Sep; 24(3):307-12. PubMed ID: 3749815
[TBL] [Abstract][Full Text] [Related]
2. Characterization of soluble terminal complement complex assembled in C8beta-deficient plasma and serum.
Høgåsen K; Mollnes TE; Nürnberger W; Pausa M; Fukumori Y; Tedesco F
Scand J Immunol; 1998 Sep; 48(3):261-8. PubMed ID: 9743210
[TBL] [Abstract][Full Text] [Related]
3. An enzyme-linked immunoabsorbent assay for the quantitation of the terminal complement complex from cell membranes or in activated human sera.
Gawryl MS; Simon MT; Eatman JL; Lint TF
J Immunol Methods; 1986 Dec; 95(2):217-25. PubMed ID: 3794343
[TBL] [Abstract][Full Text] [Related]
4. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
Tschopp J; Mollnes TE
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4223-7. PubMed ID: 2424021
[TBL] [Abstract][Full Text] [Related]
5. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
[TBL] [Abstract][Full Text] [Related]
6. Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules.
Tedesco F; Densen P; Villa MA; Petersen BH; Sirchia G
J Clin Invest; 1983 Feb; 71(2):183-91. PubMed ID: 6822660
[TBL] [Abstract][Full Text] [Related]
7. Activation-dependent epitopes in the terminal complement pathway.
Mollnes TE; Lea T; Tschopp J
Complement Inflamm; 1989; 6(3):223-35. PubMed ID: 2472924
[TBL] [Abstract][Full Text] [Related]
8. Decreased C5b67-inhibitor activity in two families with hereditary functional deficiency of the eighth component of complement.
Zeitz HJ; Zeff RA; Gewurz H; Lint TF
J Immunol; 1983 Jun; 130(6):2809-13. PubMed ID: 6854017
[TBL] [Abstract][Full Text] [Related]
9. Identification of the heterozygotes for deficiency of the beta-subunit of the eighth component of complement by reduced levels of C8 beta and increased amounts of free C8 alpha-gamma.
Nürnberger W; Wahn V; Roncelli L; Michelmann I; Seger R; Rodriguez-Valverde V; Zimran A; Goebbl U; Tedesco F
Pediatr Res; 1990 Mar; 27(3):234-8. PubMed ID: 2320389
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies.
Würzner R; Schulze M; Happe L; Franzke A; Bieber FA; Oppermann M; Götze O
Complement Inflamm; 1991; 8(5-6):328-40. PubMed ID: 1724954
[TBL] [Abstract][Full Text] [Related]
11. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
12. Differential functional expression of the C8 subunits. Primary role of C8 beta in assembly of intact C8.
Densen P; McRill CM
J Immunol; 1988 Oct; 141(8):2674-9. PubMed ID: 3171181
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of the eighth component of complement. Evidence for linkage of C8 alpha-gamma pattern with C8 beta deficiency in sera of twelve patients.
Nürnberger W; Pietsch H; Willers R; Bufon T; Hänsch GM; Seger R; Rodriguez-Valverde V; Schroten H; Hershko C; Tedesco F
Scand J Immunol; 1989 Jul; 30(1):45-9. PubMed ID: 2667094
[TBL] [Abstract][Full Text] [Related]
14. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
Stewart JL; Monahan JB; Brickner A; Sodetz JM
Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
[TBL] [Abstract][Full Text] [Related]
15. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
16. Beta chain deficiency in three patients with dysfunctional C8 molecules.
Tedesco F; Villa MA; Densen P; Sirchia G
Mol Immunol; 1983 Jan; 20(1):47-51. PubMed ID: 6855778
[TBL] [Abstract][Full Text] [Related]
17. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
Hoover DL; Berger M; Hammer CH; Meltzer MS
J Immunol; 1985 Jul; 135(1):570-4. PubMed ID: 3998474
[TBL] [Abstract][Full Text] [Related]
18. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
Hetland G; Bungum L
APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
20. Inherited deficiencies of the late-acting complement components other than C9 found among healthy blood donors.
Inai S; Akagaki Y; Moriyama T; Fukumori Y; Yoshimura K; Ohnoki S; Yamaguchi H
Int Arch Allergy Appl Immunol; 1989; 90(3):274-9. PubMed ID: 2592116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
